Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Among Key Investor Topics in CNBC Morning Squawk US GDP Growth of 2 in Early 2026 Signals Continued Economic Resilience 401k Millionaire Count Dips as Workers Boost Savings to Record Levels Fidelity Q1 Data SK Hynix and Micron Join 1 Trillion Market Cap Club on AI Chip Demand Boom Dropboxs Fully Remote Model Strengthens Recruitment and Retention as Office Return Trends Continue Marvell Stock Slides Despite Exceptional AI Demand and Upbeat Growth Forecast SNDL Q1 2026 Earnings NarrowerThanExpected Loss as Company Navigates Cannabis Market Challenges ABUS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline Keurig Dr Pepper KDP Q1 2026 Earnings EPS Surpasses Estimates with 375 Beat GFR Q1 2026 Earnings Negative EPS Disclosed Amid Limited Data Stock Rises 118 Autoliv Inc ALV Q1 2026 Earnings EPS Beat Drives Modest Stock Gain TWOD Q1 2026 Earnings Strong EPS Beat Driven by Favorable Interest Rate Environment SIFCO Industries SIF Surges 5 Key Levels to Watch Eaton Vance Floating Rate Income Trust EFT Edges Higher as Price Approaches Key Resistance Perella Weinberg Partners PWP Edges Higher Testing Resistance in a Stabilizing Advisory Market Park Ha Biological Technology BYAH Faces Continued Pressure Near Support Levels Repay Holdings RPAY Holds Steady Near Support Amid Modest Uptick PutinXi Talks to Revive Power of Siberia 2 Pipeline as Energy Markets Brace for Iran Impact Gold Weakens as Feds Waller Signals Potential Rate Hike Amid Iran Conflict Energy Risks Taiwanese Chip Testing Firm KYEC Opens Singapore Facility Set to Create Over 300 Jobs UK Spy Chiefs Moment of Consequence Warning Stirs Geopolitical Risk Debate Trump Administration Proposes GovernmentWide NonDisclosure Agreements for Federal Employees Jobless Claims Decline to Lowest Level Since MidMay Signaling Labor Market Resilience Iran Israel and Arab Nations Bound by a New Balance of Terror Market Implications Sagimet Biosciences Inc Q1 2026 Earnings Narrowed Loss Beats Expectations as Clinical Pipeline Advances Alibaba BABA Faces Resistance Near 136 as Shares Pull Back 119 Technical Levels in Focus